Cargando…
Bengamide Analogues Show A Potent Antitumor Activity against Colon Cancer Cells: A Preliminary Study
The limited success and side effects of the current chemotherapeutic strategies against colorectal cancer (CRC), the third most common cancer worldwide, demand an assay with new drugs. The prominent antitumor activities displayed by the bengamides (Ben), a family of natural products isolated from ma...
Autores principales: | García-Pinel, Beatriz, Porras-Alcalá, Cristina, Cabeza, Laura, Ortiz, Raul, Prados, José, Melguizo, Consolación, Cheng-Sánchez, Iván, López-Romero, Juan Manuel, Sarabia, Francisco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281506/ https://www.ncbi.nlm.nih.gov/pubmed/32370307 http://dx.doi.org/10.3390/md18050240 |
Ejemplares similares
-
The Development of the Bengamides as New Antibiotics against Drug-Resistant Bacteria
por: Porras-Alcalá, Cristina, et al.
Publicado: (2022) -
Lipid-Based Nanoparticles: Application and Recent Advances in Cancer Treatment
por: García-Pinel, Beatriz, et al.
Publicado: (2019) -
Biomimetic Magnetoliposomes as Oxaliplatin Nanocarriers: In Vitro Study for Potential Application in Colon Cancer
por: Garcia-Pinel, Beatriz, et al.
Publicado: (2020) -
Nanomedicine to Overcome Multidrug Resistance Mechanisms in Colon and Pancreatic Cancer: Recent Progress
por: Ortíz, Raúl, et al.
Publicado: (2021) -
Oxaliplatin–Biomimetic Magnetic Nanoparticle Assemblies for Colon Cancer-Targeted Chemotherapy: An In Vitro Study
por: Jabalera, Ylenia, et al.
Publicado: (2019)